APR 15·GlobeNewswireMed
Virbac: In the first quarter of 2025, revenue recorded solid growth of +4.9% at constant exchange rates and scope
In the first quarter of 2025, revenue recorded solid growth of +4.9% at constant exchange rates and scope ...
Virbac SA/ADR
No enriched coverage for $VRBCF in the last 7 days.
No SEC Form 4 filings for $VRBCF in the last 30 days.
In the first quarter of 2025, revenue recorded solid growth of +4.9% at constant exchange rates and scope ...